Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
New words:
ambulatory, arrive, BHVN, blocked, buyer, capped, catastrophic, CID, Cond, depletion, distinct, eliminated, entity, expertise, eye, faster, footnote, gap, influenza, IRA, Johnson, minimization, Moderna, ModernaTX, Nimenrix, NYSE, Omicron, outflow, pneumonia, pneumoniae, preliminary, President, quadrivalent, quoted, realigned, realigning, reallocated, rebate, redesign, redistributed, repayment, replaced, rollforward, Secretary, sisunatovir, sued, tear, unexpired, valuation, write
Removed:
abbreviated, adjacent, Agent, appealing, Article, attributed, autoinjector, biological, children, construction, customary, decree, EC, eligible, endpoint, engineering, EPA, epinephrine, feasibility, half, household, immune, implement, injectable, jurisdictional, living, main, NaN, notifying, pivotal, plant, preexisting, remedy, Retacrit, Ruxience, Sandoz, sterile, Switzerland, Zirabev
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view